Successful long-term management of spasticity in patients with multiple sclerosis using a software application (APP): A pilot study

被引:14
作者
Ehling, Rainer [1 ,2 ]
Edlinger, Michael [3 ]
Hermann, Kay [1 ]
Droege, Kerstin [1 ]
Seidinger, Yvonne [1 ]
Miller, Ursula [1 ]
Alber, Hannes Franz [2 ]
Brenneis, Christian [1 ,2 ]
机构
[1] Clin Rehabil Munster, Dept Neurol, Groben 700, A-6232 Munster, Austria
[2] Clin Rehabil Munster, Karl Landsteiner Inst Interdisciplinary Res, Munster, Austria
[3] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria
关键词
Multiple sclerosis; Rehabilitation; Spasticity; APP; RELIABILITY; ASHWORTH; SCALE;
D O I
10.1016/j.msard.2017.06.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Spasticity is a very common syndrome in patients with multiple sclerosis (pwMS), but available treatments lead to sufficient symptom control only in one third. Objective: To investigate the impact of an individualized training program on improving spasticity in a prospective pilot trial in pwMS suffering from moderate spasticity (defined as 4 on a normative rating scale; NRS). Methods: PwMS were familiarized with predefined exercises targeting spasticity while undergoing inpatient rehabilitation (IR). After IR, 20 pwMS were 1:1 randomized either to a newly designed APP-based home therapy program providing suitable exercises on a daily basis or to a paper-based home therapy program for 3 months. At month 3, all patients received the APP-based home program for another 3 months. Degree of spasticity was rated on the NRS. Results: Undergoing inpatient rehabilitation for a mean of 32 days led to a significant reduction in spasticity in pwMS (p = 0.00). Further self-training with the APP-based home program for 3 months led to 1.2 lower mean NRS as compared to training with the conventional paper-based program (p = 0.09). Spasticity was found to be on low levels again in both groups after 6 months. Conclusion: In pwMS, an individually tailored anti-spasticity program delivered by a software APP is a feasible tool for increasing long-term adherence to self-training thereby positively impacting spasticity in pwMS.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [1] Successful long-term management of spasticity in people with multiple sclerosis using a software application: Results from a randomized, controlled, multicenter study
    Ehling, Rainer
    Seebacher, Barbara
    Harsanyi, Andrea
    Ganzbiller, Nicole
    Papez, Stephanie
    Haider, Bernhard
    Hoertenhuber, Doris
    Kranz, Gottfried
    Tarasiewicz, Roland
    Spatt, Josef
    Moser, Hermann
    Klein, Wolfhard
    Barth, Cosmas
    Kubik, Wolfgang
    Kronberger, Eva
    Winkler, Andreas
    Brenneis, Christian
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (06) : 1697 - 1707
  • [2] Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study
    Alessandria, Giulia
    Meli, Riccardo
    Infante, Maria Teresa
    Vestito, Lucilla
    Capello, Elisabetta
    Bandini, Fabio
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 196
  • [3] TREATMENT OF SPASTICITY RELATED TO MULTIPLE SCLEROSIS WITH INTRATHECAL BACLOFEN: A LONG-TERM FOLLOW-UP
    Rekand, Tiina
    Gronning, Marit
    JOURNAL OF REHABILITATION MEDICINE, 2011, 43 (06) : 511 - 514
  • [4] Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
    Serpell, Michael G.
    Notcutt, William
    Collin, Christine
    JOURNAL OF NEUROLOGY, 2013, 260 (01) : 285 - 295
  • [5] Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
    Michael G. Serpell
    William Notcutt
    Christine Collin
    Journal of Neurology, 2013, 260 : 285 - 295
  • [6] The effect of transcutaneous electrical nerve stimulation on spasticity in multiple sclerosis patients: a pilot study
    Armutlu, K
    Meric, A
    Kirdi, N
    Yakut, E
    Karabudak, R
    NEUROREHABILITATION AND NEURAL REPAIR, 2003, 17 (02) : 79 - 82
  • [7] Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study
    Arroyo, Rafael
    Vila, Carlos
    Clissold, Steve
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (02) : 205 - 213
  • [8] Long-term effects of dalfampridine in patients with multiple sclerosis
    Ruck, T.
    Bittner, S.
    Simon, O. J.
    Goebel, K.
    Wiendl, H.
    Schilling, M.
    Meuth, S. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 337 (1-2) : 18 - 24
  • [9] Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion
    Meuth, Sven G.
    Bayas, Antonios
    Kallmann, Boris
    Kleinschnitz, Christoph
    Linker, Ralf
    Rieckmann, Peter
    Maeurer, Mathias
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (16) : 1965 - 1969
  • [10] Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients
    Sangalli, Francesca
    Moiola, Lucia
    Ferre, Laura
    Radaelli, Marta
    Barcella, Valeria
    Rodegher, Mariaemma
    Colombo, Bruno
    Boneschi, Filippo Martinelli
    Martinelli, Vittorio
    Comi, Giancarlo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (04) : 520 - 526